Vaccine language changes in paediatric and pregnancy recommendations
2 August, 2022
Further to recent changes to vaccine status across the recommendations for adults with mild COVID-19, the following paediatric and pregnancy recommendations have now been updated: Nirmatrelvir plus ritonavir (Paxlovid) for children and adolescents – consensus Remdesivir (Veklury) for children and adolescents – consensus, mild Sotrovimab (Xevudy) for children and adolescents – consensus Tixagevimab plus cilgavimab (Evusheld) for children and adolescents...
